• Research
• Back to Medicine
• Divisions
• Allergy and Inflammation
• Cardiovascular Medicine
• Center for Vascular Biology Research
• Center for Virology and Vaccine Research
• Clinical Informatics
• Clinical Nutrition
• Endocrinology
• Experimental Medicine
• Gastroenterology
• Division of General Medicine and Primary Care Section for Research
• Genetics
• Gerontology
• Hematology-Oncology Research
  • Biologic Therapy (Kidney Cancer and Melanoma) Research
  • Bone Marrow Transplantation Research
  • Breast Cancer Research
  • Cell Growth Regulation and Cancer Biology Research
  • Cellular & Molecular Biology of Hematopoiesis
  • Gastrointestinal Cancer Research
  • Genitourinary Oncology
  • Lung Cancer Research
  • Ovarian Cancer Research
  • Phase I Investigational Group
  • Research Faculty List
  • Laboratories
• Hemostasis and Thrombosis
• Immunology
• Infectious Disease
• Interdisciplinary Medicine and Biotechnology
• Matrix Biology
• Molecular and Vascular Medicine
• Nephrology
• Pulmonary, Critical Care and Sleep Medicine
• Rheumatology
• Signal Transduction
• Translational Research
• Transplant Immunology

Phase I Investigational Group

Our Mission

Our priority is to provide investigational agents that are supported by strong experimental and preclinical data to a patient population for which standard therapy is ineffective. We care for our patients with compassion, and we respect their courageous volunteerism to participate in clinical research. We are committed to maintaining the integrity of scientific research through the Dana-Farber/Harvard Cancer Center and contributing to the future of cancer therapeutics.

Who Are We?

Director: Daniel C. Cho, MD
Associate Director: Susan Pandya MD
Research Nurse: Sue Gotthardt RN, OCN
Clinical Research Specialist: Janine Morrissey
Clinical Research Assistants:  Felicia Nguyen; Kimiko Kossler
Administrative Assistant: Rena Flambo

As members of the Dana-Farber/Harvard Cancer Center (DF/HCC), the Phase I Investigational Group offers several agents with various mechanisms of action. The list of options varies and is updated accordingly. Please contact Sue Gotthardt RN, OCN at (617) 632-9272 for more information.